Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
MyHealthChecked PLC ( (GB:MHC) ) has issued an announcement.
MyHealthChecked PLC has announced a supply agreement with Boots UK Ltd to provide a selection of lateral flow self-tests and laboratory tests under the Boots’ Own Brand label. This 12-month contract includes eight blood tests, one DNA test, and four lateral flow self-tests, set to launch in August 2025. This partnership signifies a continuation of the strong relationship between the two companies, enhancing MyHealthChecked’s market presence in the growing at-home testing kit industry and potentially increasing accessibility to wellness tests for consumers.
More about MyHealthChecked PLC
MyHealthChecked PLC, based in Cardiff, is a pioneering UK healthcare company listed on AIM, specializing in at-home healthcare and wellness tests. The company offers a range of rapid tests and sample collection kits for DNA, RNA, and blood, which are analyzed in partner laboratories. These products are designed to support consumers in their wellness journeys and are available both online and over-the-counter.
Average Trading Volume: 28,311
Technical Sentiment Signal: Strong Sell
Current Market Cap: £4.93M
Learn more about MHC stock on TipRanks’ Stock Analysis page.